FDAAA and the Office of New Drugs: An Interview with Dr. John Jenkins.

Posted 01 May 2009 | By

On 5 March, Dr. John Jenkins, director of the US Food and Drug Administration's Office of New Drugs, took the time to answer some questions on the Food and Drug Administration Amendments Act posed by the RAPS Board of Editors.


Regulatory Focus newsletters

All the biggest regulatory news and happenings.